格隆汇3月31日丨康华医疗(03689.HK)发布公告,截至2024年12月31日止年度,公司报告期间收益增加0.7%至人民币2,055.7百万元。报告期间溢利减少88.5%至人民币10.5百万元。报告期间扣除利息、税项、折旧及摊销前的经调整盈利(经调整EBITDA)减少21.2%至人民币229.6百万元。董事会建议派发报告期间末期股息每股人民币15分(包括适用税项)(2023年:无)。【免责声明...
Source Link格隆汇3月31日丨康华医疗(03689.HK)发布公告,截至2024年12月31日止年度,公司报告期间收益增加0.7%至人民币2,055.7百万元。报告期间溢利减少88.5%至人民币10.5百万元。报告期间扣除利息、税项、折旧及摊销前的经调整盈利(经调整EBITDA)减少21.2%至人民币229.6百万元。董事会建议派发报告期间末期股息每股人民币15分(包括适用税项)(2023年:无)。【免责声明...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.